Metabolomics changes in patients with PAPP-A2 deficiency in response to rhIGF1 treatment

The administration of rhIGF1 resulted in changes related to crucial metabolic pathways, including lipid and protein metabolism, and this could be associated with the previously reported treatment-induced improvement in the mild basal hyperinsulinemia.